Mushrooms as Promising Therapeutic Resources: Review and Future Perspectives

Badalyan, Susanna M.; Morel, Sylvie; Barkhudaryan, Anush; Rapior, Sylvie

doi:10.1007/978-981-19-9550-7_1

Cited by 5 publications

(4 citation statements)

References 219 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Mushrooms are an enormous source of bioactive metabolites with little or negligible toxicity. Nevertheless, developing antiviral medications or vaccines for the viral infection is a challenging task, and currently, a natural source of therapy is a source to improve the immune system and reduce the death rate [ 98 ]. G. lucidum bioactive components exhibit a dynamic role in numerous human ailments, and they are measured as a source of current medication [ 44 ].…”

Section: Antimicrobial Activitymentioning

confidence: 99%

Ganoderma lucidum: Insight into antimicrobial and antioxidant properties with development of secondary metabolites

Ahmad,

A. Alsayegh,

Ahmad

et al. 2024

Heliyon

View full text Add to dashboard Cite

Section: Antimicrobial Activitymentioning

confidence: 99%

Ganoderma lucidum: Insight into antimicrobial and antioxidant properties with development of secondary metabolites

Ahmad,

A. Alsayegh,

Ahmad

et al. 2024

Heliyon

View full text Add to dashboard Cite

“…Although mushrooms have been a component of human diets for thousands of years, it has only been demonstrated in recent decades that they have a positive impact on consumer health. Many reports suggest that mushrooms have therapeutic properties [14, 75, 76]. Mushrooms have abundant antioxidants, carbohydrates, proteins, trace elements, and vitamins (Figure 2).…”

Section: Therapeutic Benefits Of Culinary‐medicinal Mushroomsmentioning

confidence: 99%

Unearthing the therapeutic benefits of culinary‐medicinal mushrooms for humans: Emerging sustainable bioresources of 21st century

Thomas,

Mago

2024

J Basic Microbiol

View full text Add to dashboard Cite

Global interest in mushroom farming techniques has grown in the last few years. Despite not making up a large amount of the human diet at the moment, the nutritional worth of mushrooms has prompted their usage. The three main segments of the global mushroom industry are wild, culinary (edible), and medicinal mushrooms. The quality food that mushrooms provide can be utilized to build agricultural ecosystems that are more sustainable for increasing productivity and enhancing the effectiveness of resource usage. This is mostly because mushrooms can be utilized for the recycling of biomass and remains from crop production. Culinary‐medicinal mushrooms are becoming more and more important because of their nutrient density, dietary value, and health advantages. Given its many bioactive components, which include polysaccharides, proteins, vitamins, minerals, dietary fiber, and secondary metabolites, mushrooms have been utilized extensively as health foods. These mushrooms exhibit pharmacological activities and possess prebiotic and antibacterial capabilities. This review provides information on the latest advancements in the sustainable cultivation of mushrooms, particularly with nontraditional substrates, and their potential therapeutic uses. Furthermore, some of the newest developments and difficulties in the production of mushrooms are explored.

show abstract

“…(Oyster mushrooms) are edible and widely cultivated worldwide. They are known as a source of valuable compounds with high nutritional and medicinal significance [2][3][4][5][6][7][8][9][10][11]. The medicinal properties of xylotrophic Pleurotus spp., as primary decomposers of wood were reported in several species, such as Pleurotus ostreatus (Jacq.)…”

mentioning

confidence: 99%

“…Moreover, submerged cultivation of mycelia allows obtaining environmentally safe different health improving biotech products. Among Oyster mushrooms, mycelial biomass and cultural broth of P. ostreatus are considered as rich sources of innovative biomedical compounds to develop nutraceuticals, nutriceuticals, pharmaceuticals and cosmeceuticals [2,3,6,7,27,28].…”

mentioning

confidence: 99%

Biomass Formation by Different Collections of $Pleurotus$ Spp. During Submerged Growth

Badalyan,

Gharibyan

2023

Proc. YSU B: Chem. Biol. Sci.

View full text Add to dashboard Cite

Many species of the genus Pleurotus (Fr.) P. Kumm. (Oyster mushrooms) are known as valuable edible and medicinal fungi, cultivated worldwide. The studied 18 different collections of five Pleurotus species (P. ostreatus, P. cornucopiae, P. eryngii, P. pulmonarius, and P. cystidiosus) during submerged growth in malt extract medium formed round shaped fluffy pellets and disperse mycelium. After seven days of cultivation, they accumulated up to 29.46 g/L biomass, while after 14 days the amount increased up to 40.4 g/L, reaching the value of commercial P. ostreatus 22 strain. More than 30.0 g/L biomass was formed in nine from 12 P. ostreatus collections, among which Armenian (SB24 and SB25), French (Po/28) and Spanish (N001) strains, as ecologically safe resources are perspective for further study to develop mushroom-based biotech products, food, pharmaceuticals and cosmeceticals.

show abstract

Mushrooms as Promising Therapeutic Resources: Review and Future Perspectives

Cited by 5 publications

References 219 publications

Ganoderma lucidum: Insight into antimicrobial and antioxidant properties with development of secondary metabolites

Ganoderma lucidum: Insight into antimicrobial and antioxidant properties with development of secondary metabolites

Unearthing the therapeutic benefits of culinary‐medicinal mushrooms for humans: Emerging sustainable bioresources of 21st century

Biomass Formation by Different Collections of $Pleurotus$ Spp. During Submerged Growth

Contact Info

Product

Resources

About